Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LINAGLIPTIN vs SAXAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LINAGLIPTIN vs SAXAGLIPTIN: Safety Overview

Metric LINAGLIPTIN SAXAGLIPTIN
Total FAERS Reports 7,762 2,468
Deaths Reported 726 263
Death Rate 9.4% 10.7%
Hospitalizations 2,794 838
Average Patient Age 70.2 yrs 65.5 yrs
% Female Patients 51.8% 47.8%
FDA Approval Date Aug 31, 2021 Jul 31, 2009
Manufacturer Novadoz Pharmaceuticals LLC Glenmark Pharmaceuticals Inc., USA
Route ORAL ORAL
Marketing Status Prescription Discontinued